Published in Eur J Pharmacol on June 01, 2005
Hypericins as potential leads for new therapeutics. Int J Mol Sci (2010) 1.23
Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One (2011) 1.11
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol (2009) 0.89
Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. Cell Death Dis (2013) 0.88
Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy. Mol Vis (2008) 0.86
Hypericin in the Light and in the Dark: Two Sides of the Same Coin. Front Plant Sci (2016) 0.79
The marine fungal metabolite, AD0157, inhibits angiogenesis by targeting the Akt signaling pathway. Mar Drugs (2014) 0.78
Neuroprotective Activity of Hypericum perforatum and Its Major Components. Front Plant Sci (2016) 0.77
In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. PLoS One (2012) 0.77
Hypericin in the Dark: Foe or Ally in Photodynamic Therapy? Cancers (Basel) (2016) 0.75
Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro. Eur Arch Otorhinolaryngol (2014) 0.75
Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect? J Invest Dermatol (2011) 1.90
Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol (2008) 1.72
Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One (2011) 1.11
Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J (2001) 1.07
Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int J Cancer (2005) 1.06
Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. Bioessays (2007) 1.05
Study of puupehenone and related compounds as inhibitors of angiogenesis. Int J Cancer (2004) 1.02
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope. J Cell Mol Med (2007) 1.00
Systems biology metabolic modeling assistant: an ontology-based tool for the integration of metabolic data in kinetic modeling. Bioinformatics (2009) 1.00
When metabolism meets topology: Reconciling metabolite and reaction networks. Bioessays (2010) 0.96
Hyperforin: more than an antidepressant bioactive compound? Life Sci (2006) 0.96
Spectroscopic analysis of recombinant rat histidine decarboxylase. J Biochem (2002) 0.93
Localization of StarD5 cholesterol binding protein. J Lipid Res (2006) 0.92
Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary. Eur J Nutr (2011) 0.91
Mammalian histidine decarboxylase: from structure to function. Bioessays (2005) 0.91
Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun (2004) 0.90
Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes with the Akt pathway. Biochem Pharmacol (2013) 0.89
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol (2009) 0.89
Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability. Eur J Biochem (2003) 0.86
Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun (2002) 0.85
ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J Lipid Res (2012) 0.84
The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway. Mar Drugs (2012) 0.83
What is known on angiogenesis-related rare diseases? A systematic review of literature. J Cell Mol Med (2012) 0.81
Global analysis of the human pathophenotypic similarity gene network merges disease module components. PLoS One (2013) 0.81
4-methylumbelliferone inhibits angiogenesis in vitro and in vivo. J Agric Food Chem (2013) 0.81
Homocysteine is a potent inhibitor of human tumor cell gelatinases. Biochem Biophys Res Commun (2003) 0.81
IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo. Mol Cancer Ther (2007) 0.80
Targeting polyamines and biogenic amines by green tea epigallocatechin-3-gallate. Amino Acids (2009) 0.80
The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells. PLoS One (2013) 0.79
Protopia: a protein-protein interaction tool. BMC Bioinformatics (2009) 0.79
Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr (2008) 0.79
A modified chorioallantoic membrane assay allows for specific detection of endothelial apoptosis induced by antiangiogenic substances. Angiogenesis (2003) 0.78
Targeting of histamine producing cells by EGCG: a green dart against inflammation? J Physiol Biochem (2010) 0.78
Raman optical activity spectra and conformational elucidation of chiral drugs. The case of the antiangiogenic aeroplysinin-1. J Phys Chem A (2011) 0.77
An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion. Biochem Biophys Res Commun (2003) 0.77
Synthesis and biological evaluation of epothilone A dimeric compounds. Bioorg Med Chem (2009) 0.77
The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells. J Cell Mol Med (2008) 0.77
Exploring and challenging the network of angiogenesis. Sci Rep (2011) 0.77
Real-time RT-PCR analysis of human histidine decarboxylase, a new marker for several types of leukemia and cancer. Oncol Rep (2006) 0.77
Information integration of protein-protein interactions as essential tools for immunomics. Cell Immunol (2007) 0.77
A novel homogenous assay for topoisomerase II action and inhibition. Chembiochem (2005) 0.76
A combined model of hepatic polyamine and sulfur amino acid metabolism to analyze S-adenosyl methionine availability. Amino Acids (2011) 0.75
Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis. PLoS One (2010) 0.75
Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2. Circ Res (2008) 0.75
DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo. J Cell Mol Med (2008) 0.75
The pursuit of creativity in biology. Bioessays (2006) 0.75